A Pilot Study of Flumist, a Live Attenuated Intranasal Influenza Vaccine, and Inactivated Influenza Vaccine in Children With Cancer.

Trial Profile

A Pilot Study of Flumist, a Live Attenuated Intranasal Influenza Vaccine, and Inactivated Influenza Vaccine in Children With Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2011

At a glance

  • Drugs Influenza virus vaccine; Influenza virus vaccine live
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms FMRESP
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Sep 2011 Results published in the Journal of Infectious Diseases.
    • 23 Sep 2011 Primary endpoint 'Haemagglutin-inhibition-antibody-levels' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top